An Alkaline Phosphatase Reporter Gene Assay for Induction of CYP3A4 In Vitro
Authors
Abstract
CYP3A4 probably has the broadest catalytic activity of any cytochrome P450. It is a crucial task to test new drug candidates in a reliable system for their ability to induce expression of this enzyme. Firstly, a total of 300 bp core distal enhancer of CYP3A4 XREM region (-7972/-7673) were amplified from human genomic DNA. The PCR product was then ligated into a human secretory alkaline phosphatase cDNA-containing reporter vector (pSEAP2-1) creating pX-SEAP2 plasmid. Secondly, 1143 bp of the CYP3A4 proximal promoter region (-1203/-61) was amplified from the genomic DNA and then ligated into pX-SEAP2 plasmid DNA (between XREM and alkaline phosphatase gene), creating pXP-SEAP2 plasmid. Reporter constructs were then co-transfected with an hPXR expression vector into human liver and intestinal cells in culture. Xenobiotic modulation of CYP3A4 promoter activity was determined by chemiluminescent secretory alkaline phosphatase assay. Significant CYP3A4 induction at the transcriptional level using three different cell lines and four classical CYP3A4 inducers was observed. Transfection of reporter constructs in HepG2, HuH7 and Caco-2 cells, in general, produced similar pattern of induction by the same drugs with the exception ofphenobarbital. The results suggest that, carefully designed reporter gene systems can provide a useful in vitro approach for characterization of possible CYP3A4 inducers.
Highlights
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Evaluation of CYP2C9 Activity in Rats: Use of Tolbutamide Alone and in Combined with Bupropion
Qiu X, Song J, Yuan H, Hou Y, Pan X, et al. Evaluation of CYP2C9 Activity in Rats: Use of Tolbutamide Alone and in Combined with Bupropion. Iran J Pharm Res. 2014;13(2):e125539. doi: https://doi.org/10.22037/ijpr.2014.1484
CYP1A1 Gene Polymorphism and Breast Cancer
Balkhi S, Mashayekhi F. CYP1A1 Gene Polymorphism and Breast Cancer. Ann Mil Health Sci Res. 2017;15(2):e63399. doi: https://doi.org/10.5812/amh.63399
Association of CYP1A2 Gene rs17861162 Polymorphism and Breast Cancer Risk in Iranian Women: A Case-control Study
Valizadeh Osalu M, Soltanzadeh H, Hojjati Bonab Z. Association of CYP1A2 Gene rs17861162 Polymorphism and Breast Cancer Risk in Iranian Women: A Case-control Study. Gene Cell Tissue. 2024;11(1):e141634. doi: https://doi.org/10.5812/gct-141634
Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells
Li K, Ding S, Chen K, Qin D, Qu J, et al. Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells. Hepat Mon. 2013;13(5):e8792. doi: https://doi.org/10.5812/hepatmon.8792
Design and Application of A Bioluminescent Biosensor for Detection Of Toxicity Using Huh7-CMV-Luc Cell Line
Rahimirad N, Kavoosi S, Shirzad H, Sadeghizadeh M. Design and Application of A Bioluminescent Biosensor for Detection Of Toxicity Using Huh7-CMV-Luc Cell Line. Iran J Pharm Res. 2019;18(2):e126211. doi: https://doi.org/10.22037/ijpr.2019.1100687
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 0
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 0
Last Update: 8 hours ago
- OpenCitations: 0
Last Update: 4 days ago